Apolipoprotein A-V: A Functional Proteomics Study

载脂蛋白 A-V：功能蛋白质组学研究

基本信息

批准号：
7216401
负责人：
ROBERT O'Mara RYAN
金额：
$ 37.95万
依托单位：
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
依托单位国家：
美国
项目类别：
财政年份：
2004
资助国家：
美国
起止时间：
2004-04-01 至 2008-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7216401
关键词：
Affect Apolipoprotein A-I Apolipoprotein E Apolipoproteins Apolipoproteins A Biological C-terminal Cardiovascular Diseases Cell Line Circular Dichroism Circular Dichroism Spectroscopy Comparative Study Condition Cultured Cells Cysteine Disruption Engineering Evaluation Family Fluorescence Fluorescence Resonance Energy Transfer Fluorescent Probes Free Energy Genes Genetic Goals Hepatic Hepatocyte Homeostasis Human Human Genome Project Knock-out Knockout Mice Knowledge Label Lipid Binding Lipids Lipoproteins Metabolism Molecular Monitor Mus Plasma Play Production Property Protein Conformation Proteins Proteomics Research Role Role playing therapy Site-Directed Mutagenesis Structure System Testing Therapeutic Intervention Transgenic Mice Transgenic Organisms Triglycerides Variant Very low density lipoprotein base cardiovascular disorder risk chemical cleavage concept genome sequencing hepatoma cell improved in vivo insight interest member novel programs research study trafficking

项目摘要

The long-term goal of our research program is to understand the molecular basis whereby exchangeable apolipoproteins regulate plasma lipid homeostasis. Recent comparative studies of human and mouse genome sequences led to the discovery of a new member of the exchangeable apolipoprotein family, apolipoprotein A-V (apoA-V). Transgenic and gene disruption experiments in mice have revealed a correlation between apoA-V and plasma triacylglycerol (TG) levels. Given the strong relationship between elevated plasma TG and risk for cardiovascular disease, apoA-V is a potential target for therapeutic intervention. The hypothesis that apoA-V modulates plasma TG levels by influencing hepatic lipoprotein assembly or secretion will be tested in primary hepatocytes from apoA-V knockout and transgenic mice as well as cultured human hepatoma cells. Studies will evaluate the extent to which apoA-V expression in liver cells affects the assembly or secretion of TG-rich lipoproteins. Conditioned medium from cultured cells will be analyzed for lipoprotein content and composition, including apoA-V levels. Fluorescence studies will examine the intracellular localization or trafficking of apoA-V in HepG2 and hepatocytes. Far U.V. circular dichroism spectroscopy will be used to characterize the free energy of unfolding and domain organization of lipid-free and lipid-associated apoA-V. Chemical cleavage of apoA-V will be performed to obtain fragments for examination of the hypothesis that the protein possesses independently folded domains. N- or C-terminal truncation variants will be engineered and characterized in terms of stability, lipid binding and biological effects. ApoA-V tertiary structure and lipid-induced conformational changes will be evaluated by fluorescence resonance energy transfer studies. Site directed mutagenesis will be performed to sequentially replace Trp residues in apoA-V, thereby generating a panel of discrete single Trp apoA-V variants. Cysteine 204 will be labeled with an extrinsic fluorescent probe and distance determinations between these donor/ acceptor pairs made. Taken together, proposed research will employ a combination of functional studies and structural characterization to improve our understanding of the mechanism whereby apoA-V modulates plasma TG levels.

我们的研究计划的长期目标是了解可交换载脂蛋白调节血浆脂质稳态的分子基础。人类和小鼠基因组序列的最新比较研究导致发现了可交换载脂蛋白家族的新成员，载脂蛋白A-V（APOA-V）。小鼠中的转基因和基因破坏实验表明，ApoA-V与血浆三酰基甘油（TG）水平之间存在相关性。鉴于血浆TG升高与心血管疾病风险之间的牢固关系，ApoA-V是治疗干预的潜在目标。 APOA-V通过影响肝脂蛋白组装或分泌来调节血浆TG水平的假设将在ApoA-V敲除和转基因小鼠以及培养的人肝癌细胞的原代肝细胞中进行测试。研究将评估肝细胞中APOA-V表达在多大程度上影响富含TG的脂蛋白的组装或分泌。将分析来自培养细胞的条件培养基的脂蛋白含量和成分，包括APOA-V水平。荧光研究将检查ApgG2和肝细胞中apoA-V的细胞内定位或运输。遥远的U.V.圆形二色性光谱将用于表征无脂质和脂质相关的ApoA-V的展开和结构域组织的自由能。将进行ApoA-V的化学切割，以获取片段以检查蛋白质具有独立折叠域的假设。 N-或C末端截断变体将以稳定性，脂质结合和生物学作用来设计和表征。 ApoA-V三级结构和脂质诱导的构象变化将通过荧光共振能量转移研究评估。将执行定向诱变的位点，以依次替换ApoA-V中的TRP残基，从而生成一组离散的单个TRP APOA-V变体。半胱氨酸204将用外在的荧光探针和这些供体/受体对之间的距离确定标记。综上所述，拟议的研究将采用功能研究和结构表征的结合，以提高我们对APOA-V调节血浆TG水平的机制的理解。